Minqiang Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Minqiang Lu has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Jialuo Mai
Department of Hepatic-Biliary-Pancreatic Surgery, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, China
6 shared publicationsJiyou Yao
Department of Hepatobiliary and Pancreatic Surgery Guangzhou First People's Hospital Guangzhou Guangdong People's Republic of China
6 shared publicationsXuefeng Hua
Department of Hepatobiliary and Pancreatic Surgery Guangzhou First People's Hospital Guangzhou Guangdong People's Republic of China
6 shared publicationsRongdang Fu
Department of Hepatic Surgery, The First People’s Hospital of Foshan, Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China
5 shared publicationsHuan Chen
Department of HBP SURGERY II, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
3 shared publicationsHuijie Wu
Department of HBP SURGERY II, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
3 shared publications
Latest Publications
- 18 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71581
Lactobacillus rhamnosus ‐Derived Extracellular Vesicles Mitigate Nonalcoholic Fatty Liver Disease Progression Through Activation of the Apelin Signaling Pathway
Non‐alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder characterized by ectopic lipid deposition in hepatocytes, currently lacks evidence‐based pharmacotherapies, rendering probiotic‐based strategies—particularly those utilizing Lactobacillus rhamnosus (LR)—a promising therapeutic avenue. Bacterial extracellular vesicles from Lactobacillus rhamnosus modulate NAFLD progression, but their molecular mechanisms remain unelucidated. Lactobacillus rhamnosus (LR‐BEVs) and Escherichia coli (E‐BEVs) were isolated via sequential ultracentrifugation, validated for morphology/size by TEM and NTA, and their uptake into THLE‐2 hepatocytes was traced with DIL fluorescent dye. In vitro, oleic acid (OA)‐induced steatosis in THLE‐2 cells was used to assess BEV effects via CCK‐8, ALT/AST/TG, IL‐1β/IL‐6, ROS, and Oil Red O. In vivo, high‐fat diet‐induced murine NAFLD evaluated BEV therapeutic potential. Mechanistically, transcriptomics, Apelin receptor inhibition (ML221), and Western blotting explored the Apelin pathway in LR‐BEV‐mediated NAFLD regulation. LR‐BEVs (~110 nm) were isolated and internalized by THLE‐2 hepatocytes. At 100 ng/mL, LR‐BEVs significantly suppressed IL‐1β and IL‐6 release in THLE‐2 cells, contrasting with the pro‐inflammatory effects of E‐BEVs. In vitro, LR‐BEVs ameliorated OA‐induced steatosis, reversing suppressed proliferation, elevated ALT/AST levels, inflammatory cytokine secretion, ROS accumulation, and lipid droplet deposition. In a murine model of high‐fat diet‐induced hepatic steatosis, LR‐BEV administration markedly attenuated hepatic lipid accumulation and concomitantly reduced serum levels of ALT, AST, TC, and TG, along with ameliorating hepatic inflammation and oxidative stress. Transcriptomic analysis implicated Apelin signaling as a key pathway modulated by LR‐BEVs, with enrichment of target genes (APLNR, SERPINE1, EGR1, ACTA2). Functional validation demonstrated that LR‐BEVs exert their anti‐steatotic effects—promoting proliferation and inhibiting lipid accumulation, ALT/AST elevation, TC, and TG increase—specifically via Apelin pathway activation, as evidenced by the abrogation of these benefits by the Apelin receptor antagonist ML221. ML221 also reversed LR‐BEV‐induced upregulation of key Apelin pathway targets. LR‐BEVs exert anti‐steatotic efficacy via the Apelin signaling pathway activation in vitro and in vivo. These findings establish LR‐BEVs as novel NAFLD therapeutics and highlight their translational potential for metabolic liver diseases.
- 18 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71581
Lactobacillus rhamnosus ‐Derived Extracellular Vesicles Mitigate Nonalcoholic Fatty Liver Disease Progression Through Activation of the Apelin Signaling Pathway
Non‐alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder characterized by ectopic lipid deposition in hepatocytes, currently lacks evidence‐based pharmacotherapies, rendering probiotic‐based strategies—particularly those utilizing Lactobacillus rhamnosus (LR)—a promising therapeutic avenue. Bacterial extracellular vesicles from Lactobacillus rhamnosus modulate NAFLD progression, but their molecular mechanisms remain unelucidated. Lactobacillus rhamnosus (LR‐BEVs) and Escherichia coli (E‐BEVs) were isolated via sequential ultracentrifugation, validated for morphology/size by TEM and NTA, and their uptake into THLE‐2 hepatocytes was traced with DIL fluorescent dye. In vitro, oleic acid (OA)‐induced steatosis in THLE‐2 cells was used to assess BEV effects via CCK‐8, ALT/AST/TG, IL‐1β/IL‐6, ROS, and Oil Red O. In vivo, high‐fat diet‐induced murine NAFLD evaluated BEV therapeutic potential. Mechanistically, transcriptomics, Apelin receptor inhibition (ML221), and Western blotting explored the Apelin pathway in LR‐BEV‐mediated NAFLD regulation. LR‐BEVs (~110 nm) were isolated and internalized by THLE‐2 hepatocytes. At 100 ng/mL, LR‐BEVs significantly suppressed IL‐1β and IL‐6 release in THLE‐2 cells, contrasting with the pro‐inflammatory effects of E‐BEVs. In vitro, LR‐BEVs ameliorated OA‐induced steatosis, reversing suppressed proliferation, elevated ALT/AST levels, inflammatory cytokine secretion, ROS accumulation, and lipid droplet deposition. In a murine model of high‐fat diet‐induced hepatic steatosis, LR‐BEV administration markedly attenuated hepatic lipid accumulation and concomitantly reduced serum levels of ALT, AST, TC, and TG, along with ameliorating hepatic inflammation and oxidative stress. Transcriptomic analysis implicated Apelin signaling as a key pathway modulated by LR‐BEVs, with enrichment of target genes (APLNR, SERPINE1, EGR1, ACTA2). Functional validation demonstrated that LR‐BEVs exert their anti‐steatotic effects—promoting proliferation and inhibiting lipid accumulation, ALT/AST elevation, TC, and TG increase—specifically via Apelin pathway activation, as evidenced by the abrogation of these benefits by the Apelin receptor antagonist ML221. ML221 also reversed LR‐BEV‐induced upregulation of key Apelin pathway targets. LR‐BEVs exert anti‐steatotic efficacy via the Apelin signaling pathway activation in vitro and in vivo. These findings establish LR‐BEVs as novel NAFLD therapeutics and highlight their translational potential for metabolic liver diseases.
- Open Access
- 25 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 6253-6269
Uniform magnetic field enhances viability of static cold storage livers and ensures transplantation efficacy
Background: In the realm of organ transplantation, static cold storage is extensively employed as the primary approach for organ preservation. Enhancing preservation technologies is vital to the quality of donor organs, which significantly influences the post-transplant survival rates and complications incidence. Thus, it is imperative to introduce innovative approaches to foster continual advancements in organ preservation. Materials and Methods: Notably, oxidative stress damage is an unavoidable occurrence during liver preservation and the ischemia-reperfusion process, leading to a decline in liver quality and consequently affecting post-transplant liver survival and patient outcomes. We have recently innovated the preservation method for rat livers by employing non-invasive physical methods to minimize oxidative stress during preservation, enhancing liver vitality in the process. Results: We established a uniform magnetic field (MF) cold storage platform, evaluating its effects on liver quality under various MF strengths. Furthermore, we conducted normothermic mechanical perfusion and rat liver transplant experiments on the preserved livers to assess the technique’s protective efficacy during the acute ischemia-reperfusion phase. Conclusion: This study proposes a straightforward approach to liver preservation and is expected to later provide technical support for critical medical practices such as liver transplantation.
- 25 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (3) , 6253-6269
Open AccessUniform magnetic field enhances viability of static cold storage livers and ensures transplantation efficacy
Background: In the realm of organ transplantation, static cold storage is extensively employed as the primary approach for organ preservation. Enhancing preservation technologies is vital to the quality of donor organs, which significantly influences the post-transplant survival rates and complications incidence. Thus, it is imperative to introduce innovative approaches to foster continual advancements in organ preservation. Materials and Methods: Notably, oxidative stress damage is an unavoidable occurrence during liver preservation and the ischemia-reperfusion process, leading to a decline in liver quality and consequently affecting post-transplant liver survival and patient outcomes. We have recently innovated the preservation method for rat livers by employing non-invasive physical methods to minimize oxidative stress during preservation, enhancing liver vitality in the process. Results: We established a uniform magnetic field (MF) cold storage platform, evaluating its effects on liver quality under various MF strengths. Furthermore, we conducted normothermic mechanical perfusion and rat liver transplant experiments on the preserved livers to assess the technique’s protective efficacy during the acute ischemia-reperfusion phase. Conclusion: This study proposes a straightforward approach to liver preservation and is expected to later provide technical support for critical medical practices such as liver transplantation.
- Open Access
Knockdown of FANCI suppresses hepatocellular carcinoma development via the PI3K/Akt/GSK-3β pathway
- Open Access
- 8 November 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-14
Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma
Hepatocellular carcinoma (HCC) associated with Hepatitis B Virus (HBV) is one of the most severe malignancies in East Asia, where early diagnosis is crucial for improving patient prognosis. So we aim to identify effective early diagnostic model for HCC. We enrolled 108 early-stage HCC patients and 102 non-HCC individuals underlying HBV infection, collecting plasma exosomal miRNAs (exo-miRNAs) from all participants. These patients were randomly assigned to sequencing, screening, training, and validation group. After preliminary screening of candidate exo-miRNAs by next-generation high-throughput sequencing, qPCR data from the screening group were utilized in conjunction with the random forest machine learning algorithm to identify candidate exo-miRNAs with diagnostic potential. Subsequently, logistic regression diagnostic model was constructed using the relative expression levels of candidate exo-miRNAs, alpha-fetoprotein (AFP) levels and clinical parameters of gender and the presence of cirrhosis from the training group. The diagnostic accuracy of diagnostic model was subsequently validated in the validation group. Firstly, we identified miR-212-5p, miR-1248, and miR-1250-5p as candidate exo-miRNAs with potential diagnostic value. The exo-miRNAs panel, which consisted of miR-212-5p, miR-1248, miR-1250-5p, along with clinical parameters of gender and cirrhosis, achieved an AUC of 0.8634 (95% CI: 0.8027–0.9241), demonstrating diagnostic performance non-inferior to AFP in the independent dataset. Subsequently, by combining exo-miRNAs, AFP level and clinical parameter of gender, we enhanced the diagnostic panel, miRAGe, which exhibited an AUC of 0.9499 (95% CI: 0.9192–0.9806), sensitivity of 0.8900, and specificity of 0.9468. Our study indicates that the miRAGe panel has low rate of both missed diagnosis and misdiagnosis rates, potentially serving as a useful diagnostic tool for HBV-related HCC in early stage, which may subsequently contribute to improve the prognosis.
- 8 November 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-14
Open AccessCross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma
Hepatocellular carcinoma (HCC) associated with Hepatitis B Virus (HBV) is one of the most severe malignancies in East Asia, where early diagnosis is crucial for improving patient prognosis. So we aim to identify effective early diagnostic model for HCC. We enrolled 108 early-stage HCC patients and 102 non-HCC individuals underlying HBV infection, collecting plasma exosomal miRNAs (exo-miRNAs) from all participants. These patients were randomly assigned to sequencing, screening, training, and validation group. After preliminary screening of candidate exo-miRNAs by next-generation high-throughput sequencing, qPCR data from the screening group were utilized in conjunction with the random forest machine learning algorithm to identify candidate exo-miRNAs with diagnostic potential. Subsequently, logistic regression diagnostic model was constructed using the relative expression levels of candidate exo-miRNAs, alpha-fetoprotein (AFP) levels and clinical parameters of gender and the presence of cirrhosis from the training group. The diagnostic accuracy of diagnostic model was subsequently validated in the validation group. Firstly, we identified miR-212-5p, miR-1248, and miR-1250-5p as candidate exo-miRNAs with potential diagnostic value. The exo-miRNAs panel, which consisted of miR-212-5p, miR-1248, miR-1250-5p, along with clinical parameters of gender and cirrhosis, achieved an AUC of 0.8634 (95% CI: 0.8027–0.9241), demonstrating diagnostic performance non-inferior to AFP in the independent dataset. Subsequently, by combining exo-miRNAs, AFP level and clinical parameter of gender, we enhanced the diagnostic panel, miRAGe, which exhibited an AUC of 0.9499 (95% CI: 0.9192–0.9806), sensitivity of 0.8900, and specificity of 0.9468. Our study indicates that the miRAGe panel has low rate of both missed diagnosis and misdiagnosis rates, potentially serving as a useful diagnostic tool for HBV-related HCC in early stage, which may subsequently contribute to improve the prognosis.
- Open Access
- 27 January 2023
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 7 (2) , e0039
Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling
Non-alcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. The gut-liver axis is a potential therapy for NASH. Sodium cholate (SC) is a choleretic drug whose main component is bile acids and has anti-inflammatory, antifibrotic, and hepatoprotective effects. This study aimed to investigate whether SC exerts anti-NASH effects by the gut-liver axis. Mice were fed with an high-fat and high-cholesterol (HFHC) diet for 20 weeks to induce NASH. Mice were daily intragastric administrated with SC since the 11th week after initiation of HFHC feeding. The toxic effects of SC on normal hepatocytes were determined by CCK8 assay. The lipid accumulation in hepatocytes was virtualized by Oil Red O staining. The mRNA levels of genes were determined by real-time quantitative PCR assay. SC alleviated hepatic injury, abnormal cholesterol synthesis, and hepatic steatosis and improved serum lipid profile in NASH mice. In addition, SC decreased HFHC–induced hepatic inflammatory cell infiltration and collagen deposition. The target protein-protein interaction network was established through Cytoscape software, and NR1H4 [farnesoid x receptor (FXR)] was identified as a potential target gene for SC treatment in NASH mice. SC-activated hepatic FXR and inhibited CYP7A1 expression to reduce the levels of bile acid. In addition, high-dose SC attenuated the abnormal expression of cancer markers in NASH mouse liver. Finally, SC significantly increased the expression of FXR and FGF15 in NASH mouse intestine. Taken together, SC ameliorates steatosis, inflammation, and fibrosis in NASH mice by activating hepatic and intestinal FXR signaling so as to suppress the levels of bile acid in NASH mouse liver and intestine.
- 27 January 2023
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 7 (2) , e0039
Open AccessSodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling
Non-alcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. The gut-liver axis is a potential therapy for NASH. Sodium cholate (SC) is a choleretic drug whose main component is bile acids and has anti-inflammatory, antifibrotic, and hepatoprotective effects. This study aimed to investigate whether SC exerts anti-NASH effects by the gut-liver axis. Mice were fed with an high-fat and high-cholesterol (HFHC) diet for 20 weeks to induce NASH. Mice were daily intragastric administrated with SC since the 11th week after initiation of HFHC feeding. The toxic effects of SC on normal hepatocytes were determined by CCK8 assay. The lipid accumulation in hepatocytes was virtualized by Oil Red O staining. The mRNA levels of genes were determined by real-time quantitative PCR assay. SC alleviated hepatic injury, abnormal cholesterol synthesis, and hepatic steatosis and improved serum lipid profile in NASH mice. In addition, SC decreased HFHC–induced hepatic inflammatory cell infiltration and collagen deposition. The target protein-protein interaction network was established through Cytoscape software, and NR1H4 [farnesoid x receptor (FXR)] was identified as a potential target gene for SC treatment in NASH mice. SC-activated hepatic FXR and inhibited CYP7A1 expression to reduce the levels of bile acid. In addition, high-dose SC attenuated the abnormal expression of cancer markers in NASH mouse liver. Finally, SC significantly increased the expression of FXR and FGF15 in NASH mouse intestine. Taken together, SC ameliorates steatosis, inflammation, and fibrosis in NASH mice by activating hepatic and intestinal FXR signaling so as to suppress the levels of bile acid in NASH mouse liver and intestine.
- Open Access
- 1 July 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (7) , 2262-2274
Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
Original Article Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma Jialuo Mai, Xuefeng Hua, Zhen-Hua Bian, Yu Xia, Zhi-Bin Zhao, Minqiang Lu
- 1 July 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (7) , 2262-2274
Open AccessIdentification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
Original Article Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma Jialuo Mai, Xuefeng Hua, Zhen-Hua Bian, Yu Xia, Zhi-Bin Zhao, Minqiang Lu
- 28 February 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (4) , e22238
LncRNA THEMIS2‐211, a tumor‐originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA
Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic. Currently, circulating exosomal lncRNA is a promising biomarker for the diagnosis of cancer and lncRNA is also a potential target in cancer therapy. Here, the diagnostic value of a panel based on exosomal lncRNA THEMIS2‐211 and PRKACA‐202, superior to that of AFP, was identified for diagnosing human HCC. Besides, the performance of exosomal lncRNA THEMIS2‐211 alone exceeds that of AFP in diagnosing early‐stage HCC patients (stage I). Furthermore, lncRNA THEMIS2‐211 is highly expressed in HCC tissues and correlated with the poor prognosis of HCC patients. LncRNA THEMIS2‐211 is upregulated and localized in the cytoplasm of HCC cells. LncRNA THEMIS2‐211 exerts its biological function as an oncogene that promotes the proliferation, migration, invasion, EMT of HCC cells by physically interacting with miR‐940 and therefore promoting SPOCK1 expressions. Rescue assays show the regulation of SPOCK1 by lncRNA THEMIS2‐211 dependents on miR‐940. The discovery of lncRNA THEMIS2‐211 further illuminates the molecular pathogenesis of HCC and the THEMIS2‐211/miR‐940/SPOCK1 axis may act as a potential therapeutic target for HCC.
- 28 February 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (4) , e22238
LncRNA THEMIS2‐211, a tumor‐originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA
Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic. Currently, circulating exosomal lncRNA is a promising biomarker for the diagnosis of cancer and lncRNA is also a potential target in cancer therapy. Here, the diagnostic value of a panel based on exosomal lncRNA THEMIS2‐211 and PRKACA‐202, superior to that of AFP, was identified for diagnosing human HCC. Besides, the performance of exosomal lncRNA THEMIS2‐211 alone exceeds that of AFP in diagnosing early‐stage HCC patients (stage I). Furthermore, lncRNA THEMIS2‐211 is highly expressed in HCC tissues and correlated with the poor prognosis of HCC patients. LncRNA THEMIS2‐211 is upregulated and localized in the cytoplasm of HCC cells. LncRNA THEMIS2‐211 exerts its biological function as an oncogene that promotes the proliferation, migration, invasion, EMT of HCC cells by physically interacting with miR‐940 and therefore promoting SPOCK1 expressions. Rescue assays show the regulation of SPOCK1 by lncRNA THEMIS2‐211 dependents on miR‐940. The discovery of lncRNA THEMIS2‐211 further illuminates the molecular pathogenesis of HCC and the THEMIS2‐211/miR‐940/SPOCK1 axis may act as a potential therapeutic target for HCC.
- Open Access
- 10 March 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
CircRNA-Mediated Regulation of Angiogenesis: A New Chapter in Cancer Biology
Angiogenesis is necessary for carcinoma progression and is regulated by a variety of pro- and anti-angiogenesis factors. CircRNAs are RNA molecules that do not have a 5’-cap or a 3’-polyA tail and are involved in a variety of biological functions. While circRNA-mediated regulation of tumor angiogenesis has received much attention, the detailed biological regulatory mechanism remains unclear. In this review, we investigated circRNAs in tumor angiogenesis from multiple perspectives, including its upstream and downstream factors. We believe that circRNAs have natural advantages and great potential for the diagnosis and treatment of tumors, which deserves further exploration.
- 10 March 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Open AccessCircRNA-Mediated Regulation of Angiogenesis: A New Chapter in Cancer Biology
Angiogenesis is necessary for carcinoma progression and is regulated by a variety of pro- and anti-angiogenesis factors. CircRNAs are RNA molecules that do not have a 5’-cap or a 3’-polyA tail and are involved in a variety of biological functions. While circRNA-mediated regulation of tumor angiogenesis has received much attention, the detailed biological regulatory mechanism remains unclear. In this review, we investigated circRNAs in tumor angiogenesis from multiple perspectives, including its upstream and downstream factors. We believe that circRNAs have natural advantages and great potential for the diagnosis and treatment of tumors, which deserves further exploration.
- 5 March 2021
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 15 (5) , 347-358
Cleavage and Polyadenylation-Specific Factor 3 Induces Cell Cycle Arrest Via Pi3K/Akt/Gsk-3β Signaling Pathways and Predicts A Negative Prognosis in Hepatocellular Carcinoma
Background: Recent studies have shown that cleavage and polyadenylation-specific factor 3 (CPSF3) is a promising antitumor therapeutic target, but its potential role in hepatocellular carcinoma (HC...
- 5 March 2021
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 15 (5) , 347-358
Cleavage and Polyadenylation-Specific Factor 3 Induces Cell Cycle Arrest Via Pi3K/Akt/Gsk-3β Signaling Pathways and Predicts A Negative Prognosis in Hepatocellular Carcinoma
Background: Recent studies have shown that cleavage and polyadenylation-specific factor 3 (CPSF3) is a promising antitumor therapeutic target, but its potential role in hepatocellular carcinoma (HC...
- Open Access
- 1 March 2021
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 53 (4) , 400-409
Interleukin 1 beta-induced chloride currents are important in osteoarthritis onset: an in vitro study
Persistent hypotonic and inflammatory conditions in the joint cavity can lead to the loss of cartilage matrix and cell death, which are the important mechanisms of osteoarthritis (OA) onset. Previous studies have confirmed that the existence of a hypotonic environment is a red flag for inflammation, as hypotonic environment induces the opening of the chloride channel of the cell and promotes chloride ion efflux, which prompts the cell volume to increase. Chloride channels play an important role in the regulation of mineralization and chondrocyte death. Here, we reported that OA chondrocytes showed a significant increase of cell death rate and the imbalance of cartilage matrix catabolism. We found that the distribution of skeleton protein F-actin was disordered. In addition, the volume-sensitive chloride current of OA chondrocytes decreased significantly with the increase of the expression levels of inflammation-related proteins caspase-1, caspase-3, and NLRP3. Moreover, interleukin-1β (IL-1β) showed a potential to activate the chloride current of normal chondrocytes. These results indicate that IL-1β-induced chloride channel opening in chondrocytes may be closely related to the occurrence of OA. This chloride channel opening process may therefore be a potential target for the treatment of OA.
- 1 March 2021
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 53 (4) , 400-409
Open AccessInterleukin 1 beta-induced chloride currents are important in osteoarthritis onset: an in vitro study
Persistent hypotonic and inflammatory conditions in the joint cavity can lead to the loss of cartilage matrix and cell death, which are the important mechanisms of osteoarthritis (OA) onset. Previous studies have confirmed that the existence of a hypotonic environment is a red flag for inflammation, as hypotonic environment induces the opening of the chloride channel of the cell and promotes chloride ion efflux, which prompts the cell volume to increase. Chloride channels play an important role in the regulation of mineralization and chondrocyte death. Here, we reported that OA chondrocytes showed a significant increase of cell death rate and the imbalance of cartilage matrix catabolism. We found that the distribution of skeleton protein F-actin was disordered. In addition, the volume-sensitive chloride current of OA chondrocytes decreased significantly with the increase of the expression levels of inflammation-related proteins caspase-1, caspase-3, and NLRP3. Moreover, interleukin-1β (IL-1β) showed a potential to activate the chloride current of normal chondrocytes. These results indicate that IL-1β-induced chloride channel opening in chondrocytes may be closely related to the occurrence of OA. This chloride channel opening process may therefore be a potential target for the treatment of OA.